4//SEC Filing
Tak Paul Peter 4
Accession 0000950170-24-129677
CIK 0001841387other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 3:07 PM ET
Size
6.9 KB
Accession
0000950170-24-129677
Insider Transaction Report
Form 4
Tak Paul Peter
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2024-11-21$1.55/sh+12,900$19,995→ 343,635 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-21−12,900→ 1,763,968 totalExercise: $1.55Exp: 2030-10-10→ Common Stock (12,900 underlying)
Footnotes (1)
- [F1]25% of this option vested and became exercisable on October 10, 2020, with another 25% vesting on October 10, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001873905
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 3:07 PM ET
- Size
- 6.9 KB